Upadacitinib Interactions
There are 599 drugs known to interact with upadacitinib, along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 380 are major, 209 are moderate, and 10 are minor.
- View all 599 medications that may interact with upadacitinib
- View upadacitinib alcohol/food interactions (2)
- View upadacitinib disease interactions (9)
Most frequently checked interactions
View interaction reports for upadacitinib and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- AndroGel (testosterone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Benylin Expectorant (dextromethorphan / guaifenesin)
- Benylin Multi-Symptom (diphenhydramine / pseudoephedrine)
- Brilinta (ticagrelor)
- Caltrate 600+D (calcium / vitamin d)
- Celebrex (celecoxib)
- Chantix (varenicline)
- Cialis (tadalafil)
- Concerta (methylphenidate)
- CoQ10 (ubiquinone)
- Creon (pancrelipase)
- Curcumin 95 (turmeric)
- D3 (cholecalciferol)
- Dexilant (dexlansoprazole)
- Dovonex (calcipotriene topical)
- Dramamine (dimenhydrinate)
- Drixoral Decongestant Non-Drowsy (pseudoephedrine)
- Efudex (fluorouracil topical)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Pentasa (mesalamine)
- Plaquenil (hydroxychloroquine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Upadacitinib alcohol/food interactions
There are 2 alcohol/food interactions with upadacitinib.
Upadacitinib disease interactions
There are 9 disease interactions with upadacitinib which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- cytopenias
- gastrointestinal perforation
- hepatic impairment
- hyperlipidemia
- vaccination
More about upadacitinib
- upadacitinib consumer information
- Compare alternatives
- Reviews (231)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.